Atossa Therapeutics, Inc. Common Stock (ATOS)

Health Care·equity
$2.44
+0.83% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
37/ 100
Score level
Below average
5 of 6 checks had data

Business numbers score is below the middle, with price trend score is near the bottom of its range.

ATOS scores higher than 45% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Atossa Therapeutics, Inc. Common Stock (ATOS) scores 37 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

Insider trades: no reading heldTrendStrengthFinancialsInsidersInsider trades: no reading heldMarketMomentum37/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
3.93× 30-day average
52-week range
1.70 – 19.35
Market cap
$22.15M
Earnings date
10 Nov 2026
Volume
265,612
Avg. volume (30d)
67,507
Open
2.45
Previous close
2.42
Day's range (regular session)
2.12 – 2.74

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
1.25
P/E (TTM)
—
EPS (TTM)
-4.34

Score breakdown · six named factors

Price trend
13
Strength vs the market
60
Company finances
0
Insider trades
—
Market mood
50
Recent momentum
69

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about ATOS right now

Atossa Therapeutics, Inc. Common Stock (ATOS) currently scores 37/100 on the Market Census six-factor composite, at the Below average score level. ATOS is +0.83% on the day and +4.70% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of ATOS's data reads poorly than well. The level is a "look before you act" flag. It is not advice. ATOS's strongest factor is recent momentum at 69/100 — a strong read on how the price has moved lately. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ATOS in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent ATOS news

Latest headlines that name Atossa Therapeutics, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

We hide 1 more that told readers to buy or sell, or gave a price target.

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to ATOS’s 37, all within 1 point.

Sorted by closeness to ATOS’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.